How Peroxide Concentration Laws Vary by Country for Teeth Whitening

Peroxide Concentration Regulations for Teeth Whitening: How Laws Differ by Country

Peroxide concentration regulations for teeth whitening are not uniform — a product legally sold over the counter in the United States could be seized as an illegal cosmetic in the European Union, and a concentration routinely used in Australian dental clinics may require special licensing elsewhere. Understanding these gaps is critical for manufacturers, dental professionals, and informed consumers alike.

The core reason regulators care so much about peroxide percentages comes down to a well-established dose-response relationship. A comprehensive review published in PMC confirms that while tooth whitening is generally safe when used as directed, higher peroxide concentrations directly increase the likelihood of tooth sensitivity and gingival irritation — two of the most commonly reported adverse effects. Concentration, exposure duration, and product formulation together determine actual risk, which is why most jurisdictions set tiered thresholds rather than a single blanket limit.

What follows is a detailed country-by-country breakdown of current peroxide limits, the regulatory logic behind each framework, and what those differences mean in practice for anyone developing, prescribing, or purchasing whitening products.

Why Peroxide Concentration Regulations Exist: The Safety Science

Before comparing national rules, it is worth grounding the discussion in the clinical evidence regulators actually rely on. The American Dental Association notes that at-home whitening products typically use 10% to 38% carbamide peroxide, and sensitivity at higher concentrations, while more frequent, tends to be mild and transient in healthy patients.

Carbamide peroxide breaks down into hydrogen peroxide and urea in the mouth, meaning the two measures are not interchangeable on a 1:1 basis. Roughly speaking, 10% carbamide peroxide yields approximately 3.5% hydrogen peroxide. Regulators in different countries have chosen different reference compounds — some set limits in hydrogen peroxide equivalents, others in carbamide peroxide — which creates an additional layer of complexity when comparing frameworks.

The pH of a whitening product also plays a measurable role in enamel safety. Health Canada explicitly requires a pH above 4.0 for regulated whitening products, acknowledging that highly acidic formulations can demineralize enamel independent of peroxide concentration. This pH threshold is one of the more granular and scientifically grounded technical requirements found in any national framework.

EU Peroxide Concentration Regulations: The 6% Hydrogen Peroxide Standard

The European Union applies the world’s most restrictive consumer-facing peroxide rules through EU Cosmetics Regulation 1223/2009. Under this framework, whitening products may contain or release up to 6% hydrogen peroxide — but only when the first use occurs under direct dental practitioner supervision. For products sold freely to consumers without any professional involvement, the permitted maximum drops to just 0.1% hydrogen peroxide.

That gap between 0.1% and 6% is not a sliding scale — it is a hard regulatory cliff. A consumer product at 0.5% hydrogen peroxide would be non-compliant, regardless of how the product is labeled or marketed.

The EU regulation includes two additional restrictions that matter in practice. First, no whitening product — regardless of concentration — may be used on anyone under 18 years of age. Second, even when a dentist initiates the first treatment with a sub-6% product, subsequent home applications by the patient are permitted only because the professional supervised that initial use. Skip the professional first use, and the product is being used outside its legal authorization.

Products exceeding 6% hydrogen peroxide are prohibited outright for tooth whitening purposes in EU member states, full stop. This creates a hard ceiling that affects not only consumer products but also the range of professional treatments available in European dental practices — a meaningful clinical constraint compared to markets like the United States or Australia.

The United Kingdom retained EU Regulation 1223/2009 into domestic law following Brexit, meaning GB-market products currently follow the same 0.1% consumer and 6% professional thresholds. Manufacturers serving both EU and UK markets therefore face identical peroxide rules across both jurisdictions, at least for now.

United States: FDA Cosmetic Framework and the Absence of a Federal Concentration Cap

The United States operates under a fundamentally different regulatory philosophy. The FDA classifies most whitening products as cosmetics — not drugs — unless the manufacturer makes therapeutic claims such as cavity prevention or enamel repair. Cosmetics do not require pre-market approval, and the FDA does not prescribe a single maximum hydrogen peroxide concentration for over-the-counter whitening products.

This means the United States has no federally mandated peroxide ceiling equivalent to the EU’s 6% consumer limit. Major retail whitening strips currently available without a prescription contain up to 14% hydrogen peroxide, a concentration that would be completely illegal for consumer sale across the EU. Professional in-office treatments commonly reach 35% to 40% hydrogen peroxide, applied under dental supervision.

The FDA’s role is not absent — it requires that cosmetic manufacturers ensure their products are safe and properly labeled, and the agency can take enforcement action against unsafe products. The burden of demonstrating safety, however, rests with the manufacturer rather than flowing through a pre-market approval gate. This places the United States at the permissive end of the global regulatory spectrum for whitening products.

When a whitening product crosses into therapeutic territory — for example, a desensitizing whitening gel marketed to treat dentinal hypersensitivity — it may fall under FDA drug regulations, which require substantially more rigorous pre-market review. The line between cosmetic and drug classification remains one of the more consequential and occasionally contested regulatory distinctions in the U.S. market. Manufacturers navigating this boundary should consider consulting dental regulatory compliance resources before finalizing product claims.

Canada: Health Canada’s Evidence-Based Tiered Approach

Health Canada occupies a middle position between the EU’s caution and the U.S. flexibility, using a tiered evidence framework built around a 3% hydrogen peroxide equivalent threshold. Products at or below that level face standard cosmetic notification requirements; products exceeding it must provide a clinical safety study before market authorization.

The requirement for exact peroxide concentration reporting — not a range, not an approximation — reflects Health Canada’s emphasis on precision in safety documentation. Manufacturers must also demonstrate pH above 4.0, making Canada one of the few jurisdictions globally to codify a pH floor alongside a peroxide ceiling.

Health Canada’s guidance on evidence requirements specifies stability data, irritation studies, and controlled clinical trial evidence for higher-concentration products. This is a more demanding evidentiary standard than most comparable consumer cosmetic categories face in Canada, signaling that regulators treat whitening as a category with elevated risk relative to typical personal care products.

The practical effect is that Canada allows moderate-concentration consumer products that would be restricted in the EU, while still requiring more rigorous documentation than the United States demands. Canadian dental professionals may use higher-concentration formulations under clinical supervision, consistent with the professional-use model common to most developed markets.

Australia: Dental Board Thresholds and Practitioner-Only Supply

Australia draws its regulatory line at 6% hydrogen peroxide or 18% carbamide peroxide. Products at or below those concentrations may be sold to consumers with appropriate warning labels. Products exceeding those thresholds are restricted to registered dental practitioners — meaning only a dentist can supply or administer them, not a beauty therapist, not a pharmacy technician, and not a whitening booth operator at a shopping mall.

The Dental Board of Australia enforces these practitioner-only supply rules as part of its broader scope-of-practice framework. The prohibition on non-dental practitioners supplying high-concentration products is explicitly stated, and enforcement actions have been taken against cosmetic businesses attempting to offer professional-strength whitening outside the dental setting.

The Australian consumer threshold of 6% hydrogen peroxide aligns precisely with the EU professional-use limit — a useful benchmark that illustrates how the same concentration can occupy entirely different regulatory tiers depending on jurisdiction. A product that requires dental supervision in France can be sold freely in an Australian supermarket.

This convergence at the 6% mark is not coincidental. Multiple regulatory bodies cite similar clinical evidence bases when justifying their thresholds, suggesting a degree of informal international harmonization around this concentration as a meaningful safety boundary for unsupervised consumer use.

Asian Markets: Japan, South Korea, and Singapore

Regulatory approaches across Asia vary considerably, reflecting differences in how each country classifies whitening products and the strength of local dental professional lobbying.

Japan

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) takes a conservative stance that has historically restricted hydrogen peroxide-based whitening products more tightly than Western markets. Peroxide-containing products that act on tooth structure have at times been classified closer to quasi-drugs or medical devices, requiring more extensive pre-market review. Consumers seeking whitening products have therefore had access to lower-concentration options than counterparts in the U.S. or Australia, with higher-concentration treatments available primarily through dental clinics.

South Korea

South Korea’s Ministry of Food and Drug Safety regulates whitening products under a cosmetics framework that permits consumer products at lower peroxide concentrations while requiring professional oversight for formulations exceeding approximately 10% hydrogen peroxide equivalent. South Korea’s position as a major cosmetic exporter means its domestic standards carry outsized influence on product development for regional markets, and local manufacturers track regulatory changes closely to maintain export eligibility.

Singapore

Singapore’s Health Sciences Authority aligns closely with international benchmarks, permitting consumer access to whitening products up to 6% hydrogen peroxide while restricting higher concentrations to dental professional use — a threshold structurally similar to both the EU professional limit and the Australian consumer ceiling. Singapore’s regulatory clarity makes it a relatively straightforward market for manufacturers already compliant with EU or Australian requirements.

For a broader look at how these differences shape purchasing decisions, see this overview of teeth whitening safety by product type.

Practical Implications: Multi-Market Product Development Under Varying Peroxide Rules

Any manufacturer attempting to sell a single whitening formulation globally will quickly discover that no single concentration satisfies every major market simultaneously. A 10% hydrogen peroxide strip legal in the United States is non-compliant for EU consumer sale by a factor of 100. A product designed for the Australian consumer market at 5% hydrogen peroxide sits comfortably under local thresholds but exceeds Canada’s enhanced documentation trigger at 3%.

The practical solution is a differentiated product portfolio: a sub-0.1% formulation for EU consumer distribution, a separate sub-6% formulation for EU dental professional supply, a higher-concentration variant for U.S. and Canadian retail, and a practitioner-only line for professional markets globally. Each variant requires region-specific labeling, safety documentation, and supply chain controls to prevent cross-market diversion.

Regulatory intelligence infrastructure is no longer optional for serious multi-market players. The EU amended Annex III of Regulation 1223/2009 to introduce the current 0.1%/6% bifurcation, replacing an earlier 0.1% blanket limit — demonstrating that peroxide concentration regulations can shift with relatively short notice. Continuous monitoring of regulatory updates across target markets, combined with pre-submission dialogue with national competent authorities, reduces the risk of costly post-launch reformulation.

Documentation standardization across markets also pays dividends. Safety assessment frameworks like the EU’s Cosmetic Product Safety Report share structural elements with Health Canada’s evidence requirements and Australia’s TGA documentation standards. Building a core safety dossier designed to satisfy the most demanding jurisdiction — typically the EU — and then supplementing it for other markets is a more efficient approach than developing separate documentation from scratch for each country.

Supply chain integrity deserves particular attention when managing multiple peroxide-concentration variants. A professional-strength formulation accidentally distributed through a consumer retail channel can expose a company to regulatory enforcement, product recall costs, and reputational damage simultaneously. Manufacturers should consult qualified cosmetic product compliance specialists when establishing multi-SKU international distribution systems.

Key Takeaways: Global Peroxide Concentration Regulations at a Glance

• European Union / United Kingdom: Consumer products capped at 0.1% hydrogen peroxide; professional supervised use permitted up to 6% hydrogen peroxide; over 6% prohibited entirely; under-18 use banned.
• United States: No federal maximum concentration for cosmetic whitening products; OTC strips commonly reach 14% hydrogen peroxide; professional treatments routinely exceed 35%; safety and labeling requirements apply.
• Canada: Enhanced clinical evidence required above 3% hydrogen peroxide equivalent; pH must exceed 4.0; exact concentration reporting mandatory.
• Australia: Consumer access up to 6% hydrogen peroxide / 18% carbamide peroxide; above those thresholds, practitioner-only supply strictly enforced.
• Singapore: Consumer products permitted up to 6% hydrogen peroxide; higher concentrations restricted to dental professionals.
• South Korea: Professional oversight required above approximately 10% hydrogen peroxide equivalent under MFDS framework.
• Japan: Conservative PMDA classification; higher-concentration products typically require dental professional administration.

The divergence in peroxide concentration regulations across these markets is not arbitrary — each framework reflects a distinct regulatory philosophy about how to balance consumer access, commercial freedom, and safety oversight. What unites all of them is the underlying clinical evidence: peroxide concentration matters, and the dose always carries consequences.

References

• Carey, C.M. (2014). Tooth Whitening: What We Now Know. Journal of Evidence-Based Dental Practice, 14(Suppl), 70–76. PMC review. https://pmc.ncbi.nlm.nih.gov/articles/PMC4058574/
• American Dental Association. (2024). Whitening — Oral Health Topics. https://www.ada.org/resources/ada-library/oral-health-topics/whitening
• U.S. Food and Drug Administration. Tooth Whitening Products — Cosmetics Products and Ingredients. https://www.fda.gov/cosmetics/cosmetics-products-ingredients/tooth-whitening-products
• Health Canada. (2023). Evidence of Safety Requirements for Tooth Whitening Products Containing Peroxide and Peroxide-Generating Compounds. https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/regulatory-information/evidence-safety-requirements-tooth-whitening-product-containing-peroxide-generating-compounds.html
• Dental Protection. Whitening Within the Law — EU and UK Regulatory Guidance. https://www.dentalprotection.org/uk/articles/whitening-within-the-law

Disclaimer

This article is for informational purposes only. LLRNCARE makes no representations or warranties about the completeness, accuracy, reliability of the information. Any reliance is at your own risk.

For professional dental advice, consult a qualified dental professional. For regulatory compliance, consult legal experts.